Acute Hepatitis in a Pediatric Patient with COVID -19 : Case Report
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The publication is free and its contents are distributed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND 4.0). The rights of the works published in this journal are property of the author and they are free to distribute and disseminate the same sources as long as he correctly cites the font of publication, these acts are not for commercial purposes and no derivative works are generated.
Main Article Content
Abstract
COVID-19 typically courses with mild clinical manifestations; however, a pediatric patient might get severe sequelae and complications when there is an infection. There is no information about liver complications due to COVID-19 in children in Mexico. This case report will set a precedent about timely diagnosis for hepatitis as a complication for COVID-19 disease in young patients in Mexico. Clinical case: A 12-years-old man has intermittent generalized abdominal pain misdiagnosed and treated for irritable bowel syndrome 3 days prior. The abdominal pain stayed, and a day after the patient vomited 3 times (each one after every meal). The patient started with orangish urine, weakness, fatigue and hyporexia 1 day prior to admission. The day of the admittance, a COVID-19 RT-PCR test was performed, giving a positive result. Once he was admitted, laboratory tests were made, showing an increase of liver enzyme levels, showing liver disease as a complication for the viral infection. Conclusion: Pediatrics patients might get Hepatitis due to COVID-19. In a patient with abdominal pain or other liver disease symptoms while coursing with the virus or even after the infection, further investigation must be made.
References
Ali, S., Prakash, S., & Murali, A. R. (2021). Hepatic Manifestations of Nonhepatotropic Infectious Agents Including Severe Acute Respiratory
Syndrome Coronavirus-2, Adenovirus, Herpes Simplex Virus, and Coxiella burnetii. Gastroenterology clinics of North America, 50(2), 383–402. https://doi.org/10.1016/j.gtc.2021.02.012
Antala, S., Diamond, T., Kociolek, L. K., Shah, A. A., & Chapin, C. A. (2022). Severe Hepatitis in Pediatric COVID-19. Journal of pediatric gastroenterology and nutrition. https://doi.org/10.1097/MPG.0000000000003404
CONACYT. (2022, 14 marzo). COVID-19 Tablero México. COVID - 19 Tablero México. Recuperado 15 de marzo de 2022, de
https://datos.covid-19.conacyt.mx
Couture, A., Lyons, B. C., Mehrotra, M. L., Sosa, L., Ezike, N., Ahmed, F. S., Brown, C. M., Yendell, S., Azzam, I. A., Katić, B. J., Cope, A., Dickerson, K., Stone, J., Traxler, L. B., Dunn, J. R., Davis, L. B., Reed, C., Clarke, K., Flannery, B., & Charles, M. D. (2022). Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Reported Coronavirus Disease 2019
Cases in US Children, August 2020-May 2021. Open forum infectious diseases, 9(3), ofac044. https://doi.org/10.1093/ofid/ofac044
Cui X, Zhao Z, Zhang T, Guo W, Guo W, Zheng J, Zhang J, Dong C, Na R, Zheng L, Li W, Liu Z, Ma J, Wang J, He S, Xu Y, Si P, Shen Y, Cai C. A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19), J Med Virol. 2021;93(2):1057-1069. DOI: 10.1002/jmv.26398
Herrera, C., Betancourt Cervantes, J., Lage Dávila, A. ., Barreto Fiu , E., Sánchez Valdés , L., Chávez González, E., & Caballero López , A. (2021). Variables associated with severity in COVID-19 patients . International Journal of Medical and Surgical Sciences, 8(3), 1–15. https://doi.org/10.32457/ijmss.v8i3.1612
León Gómez, J., Gómez Aldana, A. J., & Tapias Mantilla, M. L. (2020). Implicaciones hepáticas en la pandemia por COVID-19. Revista Colombiana De Gastroenterología, 35(Supl. 1), 30-36. https://doi.org/10.22516/25007440.535
Nikolopoulou, G. B., & Maltezou, H. C. (2022). COVID-19 in Children: Where do we Stand?. Archives of medical research, 53(1), 1–8. https://doi.org/10.1016/j.arcmed.2021.07.002
Patel N. A. (2020). Pediatric COVID-19: Systematic review of the literature. American journal of otolaryngology, 41(5), 102573. https://doi.org/10.1016/j.amjoto.2020.102573
Pedreañez, A., Mosquera-Sulbarán, J. ., Muñoz, N., Tene, D., & Robalino, J. . (2021). The disadvantage of men against COVID-19. Analysis of the influence of sex on the immune response to SARS-CoV-2 infection. International Journal of Medical and Surgical Sciences, 8(3), 1–18. https://doi.org/10.32457/ijmss.v8i3.1572
Peramo-Álvarez, F. P., López-Zúñiga, M. Á., & López-Ruz, M. Á. (2021). Medical sequels of COVID-19. Medicina clinica (English ed.), 157(8), 388–394. https://doi.org/10.1016/j.medcle.2021.04.008
Pokorska-Śpiewak, M., & Śpiewak, M. (2020). Management of hepatitis C in children and adolescents during COVID-19 pandemic. World journal of hepatology, 12(8), 485–492. https://doi.org/10.4254/wjh.v12.i8.485
U.S. Food & Drugs Administration. (2021, 2 julio). Coronavirus (COVID-19) | Drugs. U.S. Food and Drug Administration. Recuperado 23 de marzo de 2022, de
https://www.fda.gov/drugs/emergency-preparedness-drugs/coronavirus-covid- 19-drugs
Wang, D., Ju, X. L., Xie, F., Lu, Y., Li, F. Y., Huang, H. H., Fang, X. L., Li, Y. J., Wang, J. Y., Yi, B., Yue, J. X., Wang, J., Wang, L. X., Li, B., Wang, Y., Qiu, B. P., Zhou, Z. Y., Li, K. L., Sun, J. H., Liu, X. G., … Chen, Y. N. (2020). Zhonghua er ke za zhi = Chinese journal of pediatrics, 58(4), 269–274. https://doi.org/10.3760/cma.j.cn112140-20200225-00138
Yang, R. X., Zheng, R. D., & Fan, J. G. (2020). Etiology and management of liver injury in patients with COVID-19. World journal of gastroenterology, 26(32), 4753–4762. https://doi.org/10.3748/wjg.v26.i32.4753